XLS Stock | | | 27.20 1.40 4.90% |
Executive
Matthias Steffen is Managing GmbH of Xlife Sciences AG
Phone | 41 44 385 84 60 |
Web | https://www.xlifesciences.ch |
Xlife Sciences Management Efficiency
The company has return on total asset
(ROA) of
(0.0247) % which means that it has lost $0.0247 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
0.1974 %, meaning that it generated $0.1974 on every $100 dollars invested by stockholders. Xlife Sciences' management efficiency ratios could be used to measure how well Xlife Sciences manages its routine affairs as well as how well it operates its assets and liabilities.
Xlife Sciences AG has accumulated 63.47
M in total debt. Debt can assist Xlife Sciences until it has trouble settling it off, either with new capital or with free cash flow. So, Xlife Sciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Xlife Sciences AG sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Xlife to invest in growth at high rates of return. When we think about Xlife Sciences' use of debt, we should always consider it together with cash and equity.
Xlife Sciences AG (XLS) is traded on SIX Swiss Exchange in Switzerland and employs 13 people.
Management Performance
Xlife Sciences AG Leadership Team
Elected by the shareholders, the Xlife Sciences' board of directors comprises two types of representatives: Xlife Sciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Xlife. The board's role is to monitor Xlife Sciences' management team and ensure that shareholders' interests are well served. Xlife Sciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Xlife Sciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
Xlife Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Xlife Sciences a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Xlife Stock Analysis
When running Xlife Sciences' price analysis, check to
measure Xlife Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xlife Sciences is operating at the current time. Most of Xlife Sciences' value examination focuses on studying past and present price action to
predict the probability of Xlife Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xlife Sciences' price. Additionally, you may evaluate how the addition of Xlife Sciences to your portfolios can decrease your overall portfolio volatility.